Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-20

Clinical Trial Update: Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting results for sertraline combined with habit reversal therapy in patients with trichotillomania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertraline (Sertraline)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Impulse Control Disorders | Phase 4 | Status: COMPLETED